Multiplicity in randomised trials I: endpoints and treatments
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference25 articles.
1. What's wrong with Bonferroni adjustments;Perneger;BMJ,1998
2. Schulz KF, Grimes DA. Multiplicity in randomised trials II: subgroup and interim analyses. Lancet (in press).
3. Efficacy endpoint selection and multiplicity adjustment methods in clinical trials with inherent multiple endpoint issues;Sankoh;Stat Med,2003
4. No adjustments are needed for multiple comparisons;Rothman;Epidemiology,1990
5. Multiplicity in clinical trials: encyclopedia of biopharmaceutical statisitics;Westfall,2003
Cited by 310 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recommended improvements to the statistical guidelines;Ophthalmic and Physiological Optics;2024-07-23
2. Atrial Fibrillation and Older Age Predict Serum Brain-Derived Neurotrophic Factor Levels Among Patients With Heart Failure;Journal of Cardiovascular Nursing;2024-07-10
3. Protocol for a systematic review with prospective individual patient data meta-analysis in EGFR-mutant NSCLC with brain metastases to assess the effect of SRS+osimertinib compared to osimertinib alone: the STARLET Collaboration;BMJ Open;2024-07
4. Effects of Two Early Parenting Programmes on Child Aggression and Risk for Violence in Brazil: a Randomised Controlled Trial;Prevention Science;2024-07
5. Circulating TMAO, the gut microbiome and cardiometabolic disease risk: an exploration in key precursor disorders;Diabetology & Metabolic Syndrome;2024-06-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3